Clients
Tristel plc
Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, a more sustainable alternative to commonly used pre-wetted plastic wipes.
Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 270 people across 16 subsidiaries selling into 40+ countries. The Company targets annual revenue growth of between 10% and 15% and an EBITDA margin of at least 25% and the business is profitable, with no debt and has a progressive dividend policy.
The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).
The Company will host two investor presentations on consecutive days, Tuesday 29 July 2025 and Wednesday 30 of July 2025. Details of the two events are below:
Capital Markets Day
The Capital Markets Day will be hosted in the City of London on Tuesday 29 July 2025. The event will commence at 14:30pm BST and welcomes Institutional Investors and Analysts. For more information and to register please contact Walbrook PR via [email protected].
Shareholder Open Day
The Shareholder Open Day will be hosted at the Company's headquarters in Snailwell, Cambridgeshire on Wednesday 30 July 2025. Shareholders are welcome from 12:00pm BST. Availability is limited so please contact Walbrook PR via [email protected] or call 020 7933 8780 to reserve an entry ticket.| Event | Date |
| Year End | 30 June |
| Half Year End | 31 December |
| Preliminary Results* | October |
| Interim Results* | February |
| AGM* | December |
* Months based on previous announcements of this kind
TSTL - Investor Presentation - Feb 2025
TSTL Company Summary June 2025
Who We Work With
Tristel plc
Tristel plc is a global infection prevention company focussed on the manufacture and supply of products using its unique proprietary chlorine dioxide (ClO2) chemistry. The Company is a market leader in manual decontamination of medical devices, supplying hospitals under the Tristel brand, and under the Cache brand provides products for sporicidal surface disinfection, a more sustainable alternative to commonly used pre-wetted plastic wipes.
Tristel's head office and manufacturing facility is located in Snailwell, near Cambridge, and operates globally employing approximately 270 people across 16 subsidiaries selling into 40+ countries. The Company targets annual revenue growth of between 10% and 15% and an EBITDA margin of at least 25% and the business is profitable, with no debt and has a progressive dividend policy.
The Company has been listed on the London Stock Exchange's AIM market since 2005 (AIM: TSTL).
The Company will host two investor presentations on consecutive days, Tuesday 29 July 2025 and Wednesday 30 of July 2025. Details of the two events are below:
Capital Markets Day
The Capital Markets Day will be hosted in the City of London on Tuesday 29 July 2025. The event will commence at 14:30pm BST and welcomes Institutional Investors and Analysts. For more information and to register please contact Walbrook PR via [email protected].
Shareholder Open Day
The Shareholder Open Day will be hosted at the Company's headquarters in Snailwell, Cambridgeshire on Wednesday 30 July 2025. Shareholders are welcome from 12:00pm BST. Availability is limited so please contact Walbrook PR via [email protected] or call 020 7933 8780 to reserve an entry ticket.| Event | Date |
| Year End | 30 June |
| Half Year End | 31 December |
| Preliminary Results* | October |
| Interim Results* | February |
| AGM* | December |
* Months based on previous announcements of this kind
TSTL - Investor Presentation - Feb 2025
TSTL Company Summary June 2025
Leave a comment